Human ceIII ine derived from gastric cancer. TKG0411 (Deposited fromTohoku un iv. ) .

Human ceIII ine derived from gastric
cancer. TKG0411  (Deposited fromTohoku
un iv. ) . Struktur
CAS-Nr.
Englisch Name:
Human ceIII ine derived from gastric cancer. TKG0411 (Deposited fromTohoku un iv. ) .
Synonyma:
H-111-TC;Human ceIII ine derived from gastric cancer. TKG0411 (Deposited fromTohoku un iv. ) .
CBNumber:
CB521463355
Summenformel:
Molgewicht:
0
MOL-Datei:
Mol file

Human ceIII ine derived from gastric cancer. TKG0411 (Deposited fromTohoku un iv. ) . Eigenschaften

Sicherheit

Human ceIII ine derived from gastric cancer. TKG0411 (Deposited fromTohoku un iv. ) . Chemische Eigenschaften,Einsatz,Produktion Methoden

Human ceIII ine derived from gastric cancer. TKG0411 (Deposited fromTohoku un iv. ) . Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


Human ceIII ine derived from gastric cancer. TKG0411 (Deposited fromTohoku un iv. ) . Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 1)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Guangdong Fanpu Biotechnology Co., Ltd. 19513720913
2708713838@qq.com China 4720 58

  • Human ceIII ine derived from gastric cancer. TKG0411 (Deposited fromTohoku un iv. ) .
  • H-111-TC
Copyright 2019 © ChemicalBook. All rights reserved